Renal Safety of Tenofovir Disoproxil Fumarate in HIV-1 Treatment-experienced Patients with Adverse Events Related to Prior NRTI UseSantiago Moreno, María Luisa Álvarez, Peré Domingo et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 30
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019Chiara Fanciulli, José Antonio Iribarren, Luís Morano et al.|HIV Medicine|2022Cited by 28
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Álvarez, Luis Miguel Garcia Sousa, Paz Casas et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 22
Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in SpainVicente Estrada, Arturo Fernández Cruz, José Ignacio Bernardino et al.|HIV Clinical Trials|2015Cited by 21
Análisis de los costes asociados a la administración intramuscular versus oral de la terapia antirretroviral en el manejo de la infección por el virus de la inmunodeficiencia humanaVicente Estrada, Laura Salinas-Ortega, Juan Emilio Losa et al.|Enfermedades Infecciosas y Microbiología Clínica|2024Cited by 2